Skip to main content
. 2019 Jan 9;8(2):629–642. doi: 10.1002/cam4.1966

Figure 3.

Figure 3

Forest plots of HR of OS associated with nivolumab vs docetaxel (including subgroup analysis according to PD‐L1 expression)